Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part V)

Author(s): Mohammad Amjad Kamal and Md Asaduzzaman Khan

Volume 28, Issue 12, 2022

Published on: 06 June, 2022

Page: [947 - 947] Pages: 1

DOI: 10.2174/138161282812220606124424

« Previous Next »
[1]
https://covid19.who.int/
[2]
Kamal MA, Khan MA. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part I). Curr Pharm Des 2020; 26(41): 5221-3.
[3]
Kamal MA, Khan MA. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II). Curr Pharm Des 2021; 27(9): 1121-2.
[4]
Kamal MA, Khan MA. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part III). Curr Pharm Des 2021; 27(32): 3423.
[5]
Kamal MA, Khan MA. Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part IV). Curr Pharm Des 2021; 27(33): 3501.
[6]
Rahman MM, Ahmed M, Islam MT, et al. Nanotechnology-based approaches and investigational therapeutics against COVID-19. Curr Pharm Des 2022; 28(12): 948-68.
[7]
Murali M, Gowtham HG, Ansari MA, et al. Repositioning therapeutics for SARS-CoV-2: Virtual screening of plant-based Anti-HIV compounds as possible inhibitors against COVID-19 viral RdRp. Curr Pharm Des 2022; 28(12): 969-80.
[8]
Ghamdi FA, Naqvi S, Alabassi FA, et al. Alterations in clinical characteristics of blood donors post COVID-19 recovery. Curr Pharm Des 2022; 28(12): 981-92.

Rights & Permissions Print Cite
Article Metrics
14
1
© 2024 Bentham Science Publishers | Privacy Policy